News

You cannot treat all employees equally, but you should treat them fairly. There’s a big difference between the two, and ...
RBC Capital analyst Luca Issi initiated coverage with a Buy rating on Ascendis Pharma (ASND – Research Report) yesterday and set a price target ...
RBC Capital initiated coverage of Ascendis Pharma (ASND) with an Outperform rating and $205 price target. The stock has outperformed the ...
Shifting federal guidelines are reshaping employee relations, meaning the work of ER teams is more important than ever.